Successful Use of Low Dose r-Hirudin (Refludan®) for Recurrent Dialysis Catheter Thrombosis in a Patient with Heparin Induced Thrombocytopenia

Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.

Facebook X Linkedin Weibo

PDF herunterladen

Thromb Haemost 1999; 82(03): 1205-1206
DOI: 10.1055/s-0037-1614360

Letters to the Editor

Schattauer GmbH

Successful Use of Low Dose r-Hirudin (Refludan^®) for Recurrent Dialysis Catheter Thrombosis in a Patient with Heparin Induced Thrombocytopenia

Viren B. Patel

¹From The University of Nevada School of Medicine, Reno, NV

,

Joseph Snyder

²The University Medical Center, Las Vegas, NV

,

Rinah I. Shopnick

³The Hemophilia and Thrombosis Center of Nevada, Las Vegas, USA

Weitere Informationen

Received 26. Februar 1999

Accepted 02. Mai 1999

Publikationsdatum:
09. Dezember 2017 (online)

References
1 Hoechst Marion Roussel. Package literature for Refludan^® . March 1998

PubMed Suche in Google Scholar
2 Vanholder R, Camez A, Veys N, Van Loo A, Dhond AM, Ringoir S. Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients. Thromb Haemost 1997; 77 (04) 650-5.

Thieme Connect PubMed Suche in Google Scholar